Literature DB >> 7487491

Membrane related effects in endothelial cells induced by human cytomegalovirus.

A G van Geelen1, M E Slobbe-van Drunen, A D Muller, C A Bruggeman, M C Van Dam-Mieras.   

Abstract

Previously, we have reported on the increase in procoagulant activity of human umbilical vein endothelial cells (HUVEC) after infection with human cytomegalovirus (HCMV). When using microvascular endothelial cells from foreskin (MVEC), we also observe a significant increase in membrane perturbation and a concomittant increase in procoagulant activity. This effect is both observed with a laboratory HCMV strain (AD169) with low pathogenicity for endothelium and a HUVEC adapted strain (VHL-E) that readily infects endothelial cells. We compared the membrane perturbation of two types of endothelial cells, HUVEC and MVEC with human embryonal fibroblasts (HEF), being fully permissive for both strains. A membrane effect was only found in endothelial cells. Our results suggest that HCMV induces in MVEC more merocyanine-540 incorporation in the membrane as in HUVEC. The increase in the procoagulant activity induced by HCMV was more pronounced in MVEC than in HUVEC. Inactivated virus, as well as virus pre-incubated with heparin was unable to evoke membrane perturbation. It therefore appears that HCMV induces a rapid membrane response in vascular endothelium and that physical interaction of the virion and the endothelial cell is required to elicit this response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487491     DOI: 10.1007/bf01322533

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  56 in total

Review 1.  The possible role of cytomegalovirus in atherogenesis.

Authors:  C A Bruggeman; M C van Dam-Mieras
Journal:  Prog Med Virol       Date:  1991

Review 2.  Leukocyte extravasation: mechanisms and consequences.

Authors:  T W Kuijpers; D Roos
Journal:  Behring Inst Mitt       Date:  1993-08

3.  Widespread presence of histologically occult cytomegalovirus.

Authors:  D Myerson; R C Hackman; J A Nelson; D C Ward; J K McDougall
Journal:  Hum Pathol       Date:  1984-05       Impact factor: 3.466

4.  High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis.

Authors:  M G Hendrix; M M Salimans; C P van Boven; C A Bruggeman
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

5.  Endothelial cell presentation of antigen to human T cells.

Authors:  D R Burger; D Ford; R M Vetto; A Hamblin; A Goldstein; M Hubbard; D C Dumonde
Journal:  Hum Immunol       Date:  1981-11       Impact factor: 2.850

6.  Detection of neutralizing antibodies against human cytomegalovirus: influence of strain variation.

Authors:  B Weber; U Klinghardt; A Lux; W Braun; H Rabenau; H W Doerr
Journal:  J Med Virol       Date:  1993-05       Impact factor: 2.327

7.  Interleukin-1 production and cell-activation response to cytomegalovirus infection of vascular endothelial cells.

Authors:  S B Woodroffe; H M Garnett; V A Danis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Human cytomegalovirus alters interleukin-6 production by endothelial cells.

Authors:  G D Almeida; C D Porada; S St Jeor; J L Ascensao
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

9.  Cytomegalovirus alters the von Willebrand factor content in human endothelial cells.

Authors:  C A Bruggeman; W H Debie; A D Muller; B Schutte; M C van Dam-Mieras
Journal:  Thromb Haemost       Date:  1988-04-08       Impact factor: 5.249

10.  Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia.

Authors:  R Mahalingam; M C Wellish; A N Dueland; R J Cohrs; D H Gilden
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

View more
  1 in total

1.  Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation.

Authors:  Afsar Rahbar; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.